Unibest

Pharmaceutical intermediates

Ozenoxacin Intermediates

3 pharmaceutical intermediates for Ozenoxacin. Indication: Infectious skin diseases; Furuncle; Acne vulgaris.

提交项目All intermediates

About Ozenoxacin

Originator
Takayama Chemical Co., Ltd
Indication
Infectious skin diseases; Furuncle; Acne vulgaris
Approved Date
12/11/2017
DS/DP
12/15/2027

Available intermediates

3 intermediates currently listed for Ozenoxacin. Request specifications, documentation or a quotation for any item below.

Ozenoxacin intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
ethyl 7-chloro-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate103877-51-6//
5-broMo-N,3-diMethylpyridin-2-aMine245765-66-6//
[6-[benzoyl(methyl)amino]-5-methyl-3-pyridyl]boronic acid446299-81-6//

Other programs under O

OfloxacinOlaparibOliceridineOmadacycline toslateOrforglipronOSIMERTINIB MESYLATE

Building toward Ozenoxacin?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →